REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 182 filers reported holding REGENXBIO INC in Q2 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,516,000 | -79.2% | 46,369 | -73.3% | 0.02% | -76.9% |
| Q3 2021 | $7,287,000 | -57.8% | 173,840 | -60.9% | 0.09% | -54.5% |
| Q2 2021 | $17,286,000 | +100.3% | 444,939 | +75.9% | 0.20% | +102.0% |
| Q1 2021 | $8,630,000 | -24.8% | 253,002 | 0.0% | 0.10% | -17.5% |
| Q4 2020 | $11,476,000 | +185.5% | 253,002 | +73.3% | 0.12% | +150.0% |
| Q3 2020 | $4,019,000 | -37.0% | 146,028 | -15.7% | 0.05% | -45.5% |
| Q2 2020 | $6,379,000 | +16.6% | 173,192 | +2.5% | 0.09% | -5.4% |
| Q1 2020 | $5,469,000 | -53.9% | 168,905 | -41.6% | 0.09% | -41.1% |
| Q4 2019 | $11,852,000 | -73.2% | 289,281 | -76.7% | 0.16% | -71.7% |
| Q3 2019 | $44,276,000 | -37.6% | 1,243,721 | -10.0% | 0.56% | -36.6% |
| Q2 2019 | $71,007,000 | +93.8% | 1,382,262 | +116.3% | 0.88% | +106.6% |
| Q1 2019 | $36,632,000 | +409.7% | 639,195 | +273.1% | 0.43% | +291.7% |
| Q4 2018 | $7,187,000 | -14.5% | 171,326 | +53.9% | 0.11% | +53.5% |
| Q3 2018 | $8,404,000 | +50.2% | 111,306 | +42.7% | 0.07% | +69.0% |
| Q2 2018 | $5,597,000 | – | 78,001 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 415,664 | $15,309,000 | 7.62% |
| Aquilo Capital Management, LLC | 553,453 | $20,384,000 | 4.11% |
| ArchPoint Investors | 300,961 | $11,084,000 | 3.55% |
| Burrage Capital Management LLC | 115,000 | $4,235,000 | 2.96% |
| P.A.W. CAPITAL CORP | 70,000 | $2,578,000 | 2.92% |
| WS MANAGEMENT LLLP | 436,828 | $16,088,000 | 1.97% |
| Redmile Group, LLC | 2,236,766 | $82,380,000 | 1.52% |
| BRANDYWINE MANAGERS, LLC | 6,200 | $228,000 | 0.94% |
| Pier Capital, LLC | 94,433 | $3,478,000 | 0.56% |
| RTW INVESTMENTS, LP | 316,028 | $11,639,000 | 0.33% |